NanoSyrinx
PrivateLast Round
Series A
Sep 10, 2024
Total Funding Raised
$22.32M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NanoSyrinx is a biotechnology company that develops a synthetic biology platform for the targeted intracellular delivery of therapeutic proteins and peptides.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoSyrinx Comparables
Compare NanoSyrinx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyGenica | 83% | |
| Sapreme Technologies BV | 82% | |
| Xelcis Bio, Inc. | 80% | |
NanoSyrinx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 10, 2024 | ||||
| Seed | Jul 14, 2021 | ||||
| Grant | Sep 30, 2020 | ||||
| Pre Seed | Sep 30, 2020 | ||||
| Grant | Jun 30, 2020 |
Key People
Founding team and executive leadership
NanoSyrinx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Grant |
| BGF | Series A |
| Pioneer Group | Seed, Pre Seed |
| M Ventures | Seed, Pre Seed, Series A |
| Meltwind Advisory | Series A |
| IQ Capital | Seed, Series A |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 202% MoM, reaching 1.5K.
- Jan 8, 2026
Thomas J. Farrell appointed as new Chief Executive Officer.
NanoSyrinx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NanoSyrinx's valuation, stock price, and market status.